Evaluation of circulating Activin-A as a serum marker of hepatocellular carcinoma.

被引：0
|
作者：
Pirisi, M
Fabris, C
Luisi, S
Santuz, M
Soardo, G
Toniutto, P
Vitulli, D
Federico, E
Del Forno, M
Petraglia, F
机构：
[1] Univ Udine, DPMSC, I-33100 Udine, Italy
[2] Univ Udine, Cattedra Ostet & Ginecol, I-33100 Udine, Italy
[3] Univ Pisa, Cattedra Ostet & Ginecol, Pisa, Italy
来源：
HEPATOLOGY | 1998年 / 28卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
2396
引用
收藏
页码：761A / 761A
页数：1
相关论文
共 50 条
  • [21] Development of a new tumor marker against human hepatocellular carcinoma.
    Yoon, SK
    Kim, JW
    Lim, NK
    Kang, EH
    Kim, SH
    Chang, UI
    Cho, SH
    Sun, HS
    HEPATOLOGY, 2002, 36 (04) : 302A - 302A
  • [22] Glypican-3: A novel diagnostic marker for hepatocellular carcinoma.
    Sherman, M
    Filmus, J
    Wanless, I
    Capurro, M
    HEPATOLOGY, 2002, 36 (04) : 692A - 692A
  • [23] Serum Activin-A levels in metabolic bone diseases.
    Nuti, R
    Martini, G
    Florio, G
    Valenti, R
    Salvadori, S
    Picchi, A
    Petraglia, F
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S254 - S254
  • [24] Using the ALBI grade as a prognostic marker for radioembolization of hepatocellular carcinoma.
    Mohammadi, Homan
    Abuodeh, Yazan
    Jin, Will
    Frakes, Jessica M.
    Friedman, Mark
    Biebel, Benjamin
    Choi, Junsung
    El-Haddad, Ghassan
    Kis, Bela
    Sweeney, Jennifer
    Kim, Richard D.
    Pimiento, Jose Mario
    Malafa, Mokenge Peter
    Anaya, Daniel A.
    Hoffe, Sarah E.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [25] Glypican-3 is a potential tumor marker for hepatocellular carcinoma.
    Kleeff, JH
    Zhu, ZW
    Wang, L
    Zimmermann, A
    Korc, M
    Friess, H
    Buchler, MW
    GASTROENTEROLOGY, 2000, 118 (04) : A261 - A261
  • [26] Clinical evaluation of AFP-L3: a now tumor marker for aggressive hepatocellular carcinoma.
    Li, DJ
    Henmi, F
    Yamagata, Y
    Nakamura, K
    Mallory, T
    Satomura, S
    CLINICAL CHEMISTRY, 2002, 48 (06) : A19 - A19
  • [27] Circulating MicroRNA Panel as a Diagnostic Marker for Hepatocellular Carcinoma
    Wu, Xiaochang
    Wan, Renrui
    Ren, LingYan
    Yang, Yong
    Ding, Yuan
    Wang, Weilin
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2022, 33 (10): : 844 - 851
  • [28] Serum CA 125 as a marker of hepatocellular carcinoma
    Lopez, JB
    Balasegaram, M
    Thambyrajah, V
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 1996, 11 (03): : 178 - 182
  • [29] Serum neopterin as a marker for screening of hepatocellular carcinoma
    Tsuda, Y
    Fukuda, A
    Kobayashi, H
    Itou, D
    Yoshimoto, S
    Iwata, K
    Hanafusa, T
    PTERIDINES, 2004, 15 (04) : 161 - 169
  • [30] SERUM FOLLISTATIN AS A PROGNOSTIC MARKER FOR HEPATOCELLULAR CARCINOMA
    Nouso, Kazuhiro
    Tomoda, Takeshi
    Kobayashi, Sayo
    Miyahara, Koji
    Hagihara, Hiroaki
    Kuwaki, Kenji
    Onishi, Hideki
    Nakamura, Shinichiro
    Shiraha, Hidenori
    Takaki, Akinobu
    Yamamoto, Kazuhide
    HEPATOLOGY, 2011, 54 : 1375A - 1376A
12345